The website shows 6 indications in phase 3 Trials..
Including Fragile X, unannounced disease and PDD!
Yeah we have some news coming our way.
Anavex is now a different company though nothing has changed during the week. But what a week ! (thanks to SAVA - no doubt about that). This is a huge change for a small cap company in the biotech sector.
Almost every investing entity focusing (on biotech especially), on Wallstreet now knows about Anavex. I am sure they must have taken a good look into what the company is doing, the pipeline, trials and the data read outs so far.
Now we have some tweets from the company, even though I do not see much value-addition at this stage. (But wont hurt either).
When Anavex starts announcing results or important events in its PRs, there will be more parties interested including some big investors.
We will know pretty soon if this change is real, benefiting longs. (Call it a welcome change)
Hoping for the best.